%0 Journal Article
%B Diabetes, Obesity and Metabolism
%D 2020
%P 46 - 54
%T Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY
%V 22